NDC 64193-423

FEIBA

Anti-inhibitor Coagulant Complex

FEIBA is a Kit in the Human Prescription Drug category. It is labeled and distributed by Baxalta Incorporated. The primary component is .

Product ID64193-423_4043cc82-6f4d-4241-b6a0-e55a92c5e53b
NDC64193-423
Product TypeHuman Prescription Drug
Proprietary NameFEIBA
Generic NameAnti-inhibitor Coagulant Complex
Dosage FormKit
Marketing Start Date1986-01-31
Marketing CategoryBLA / BLA
Application NumberBLA101447
Labeler NameBaxalta Incorporated
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC SPL Data Element Entries

NDC 64193-423-02 [64193042302]

FEIBA KIT
Marketing CategoryBLA
Application NumberBLA101447
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1986-01-31
Marketing End Date2019-03-31

Drug Details

OpenFDA Data

SPL SET ID:752604e5-4ea2-44f4-83ed-1569373f6412
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 1659998
  • 1660001
  • NDC Crossover Matching brand name "FEIBA" or generic name "Anti-inhibitor Coagulant Complex"

    NDCBrand NameGeneric Name
    64193-423FEIBAanti-inhibitor coagulant complex
    64193-424FEIBAanti-inhibitor coagulant complex
    64193-425FEIBAanti-inhibitor coagulant complex
    64193-426FEIBAanti-inhibitor coagulant complex

    Trademark Results [FEIBA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    FEIBA
    FEIBA
    73416395 1313032 Live/Registered
    Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte
    1983-03-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.